Aging men and lipids

American Journal of Men's Health

Volumn 5, Issue 2, 2011, Pages 152-165

  Kolovou, Genovefa ^a   Bilianou, Helen ^b   Marvaki, Apostolia ^a   Mikhailidis, Dimitri P ^c  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Aging; Andropause; Lipids; Men

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TESTOSTERONE;

AGE; AGING; ANDROPAUSE; ARTICLE; BLOOD; BODY COMPOSITION; BODY MASS; DYSLIPIDEMIA; GENOTYPE; HEALTH STATUS; HUMAN; LIFESTYLE; LIPID METABOLISM; MALE; METABOLISM; PATHOLOGY; UNITED STATES;

AGE FACTORS; AGING; ANDROPAUSE; BODY COMPOSITION; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DYSLIPIDEMIAS; ESTROGENS; GENOTYPE; HEALTH STATUS; HUMANS; LIFE STYLE; LIPID METABOLISM; LIPIDS; MALE; RECEPTORS, ANDROGEN; TESTOSTERONE; UNITED STATES;

EID: 79952260050     PISSN: 15579883     EISSN: 15579891     Source Type: Journal    
DOI: 10.1177/1557988310370360     Document Type: Article

References (157)

1. Alexandersen, P., Haarbo, J., & Christiansen, C. (1996). The relationship of natural androgens to coronary heart disease in males: A review. Atherosclerosis, 125, 1-13.
2. Anawalt, B.D., & Merriam, G.R. (2001). Neuroendocrine aging in men. Andropause and somatopause. Endocrinology and Metabolism Clinics of North America, 30, 647-669.
3. Andersen, A.G., Jensen, T.K., Carlsen, E., Jørgensen, N., Andersson, A.M., Krarup, T., . . . Skakkabaek, N.E. (2000). High frequency of sub-optimal semen quality in an unselected population of young men. Human Reproduction, 15, 366-372.
4. Angelopoulos, J., Krassakopoulos, N., Nathanson, R., Boukas, S., & Sampalis, J.S. (2009). Co-administration of ezetimibe and a statin in management of dyslipidemias: A meta-analysis of clinical trials. Archives of Medical Science, 5, 347-363.
5. Ariyasu, H., Iwakura, H., Yamada, G., Nakao, K., Kangawa, K., & Akamizu, T. (2008). Efficacy of ghrelin as a therapeutic approach for age-related physiological changes. Endocrinology, 149, 3722-3728.
6. Bagatell, C.J., & Bremner, W.J. (1995). Androgen and progestagen effects on plasma lipids. Progress in Cardiovascular Diseases, 38, 255-271.
7. Bagatell, C.J., & Bremner, W.J. (1996). Androgens in men: Uses and abuses. New England Journal of Medicine, 334, 707-714.
8. Bain, J. (2007). The many faces of testosterone. Clinical Interventions in Aging, 2, 567-576.
9. Baker, H.W., Burger, H.G., de Kretser, D.M., Hudson, B., O'Connor, S., Wang, C.,. . . Rennie, J.C. (1976). Changes in the pituitary-testicular system with age. Clinical Endocrinology, 5, 349-372.
10. Bakhshi, V., Elliott, M., Gentili, A., Godschalk, M., & Mulligan, T. (2000). Testosterone improves rehabilitation outcomes in ill older men. Journal of the American Geriatrics Society, 48, 550-553.
11. Bartke, A. (2003). Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice. Neuroendocrinology, 78, 210-216.
12. Baskin, H.J., Cobin, R.H., Duick, D.S., Gharib, H., Guttler, R.B., Kaplan, M.M., . . . American Association of Clinical Endocrinologists. (2002). American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocrine Practice, 8, 457-469.
13. Bassil, N., Alkaade, S., & Morley, J.E. (2009). The benefits and risks of testosterone replacement therapy: A review. Therapeutics and Clinical Risk Management, 5, 427-448.
14. Basu, R., Breda, E., Oberg, A.L., Powell, C.C., Dalla Man, C., Basu, A., . . . Rizza, R.A. (2003). Mechanisms of the age-associated deterioration in glucose tolerance: Contribution of alterations in insulin secretion, action, and clearance. Diabetes, 52, 1738-1748.
15. Beydoun, M.A., & Wang, Y. (2009). Gender-ethnic disparity in BMI and waist circumference distribution shifts in US adults. Obesity(Silver Spring, Md), 17, 169-176.
16. Bjorntorp, P., & Ostman, J. (1971). Human adipose tissue dynamics and regulation. Advances in Metabolic Disorders, 5, 277-327.
17. Blackman, M.R. (2008). Use of growth hormone secretagogues to prevent or treat the effects of aging: Not yet ready for prime time. Annals of Internal Medicine, 149, 677-679.
18. Boyanov, M.A., Boneva, Z., & Christov, V.G. (2003). Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male, 6, 1-7.
19. Campisi, J. (2005). Senescent cells, tumor suppression and organismal aging: Good citizens, bad neighbors. Cell, 120, 513-522.
20. Carruthers, M. (2009). Time for international action on treating testosterone deficiency syndrome. Aging Male, 12, 21-28.
21. Casiglia, E., Mazza, A., Tikhonoff, V., Scarpa, R., Schiavon, L., & Pessina, A.C. (2003). Total cholesterol and mortality in the elderly. Journal of Internal Medicine, 254, 353-362.
22. Cefalu, W.T., Bell-Farrow, A.D., Wang, Z.Q., Sonntag, W.E., Fu, M.X., Baynes, J.W., & Thorpe, S.R. (1995). Caloric restriction decreases age-dependent accumulation of the glycoxidation products, N epsilon-(carboxymethyl)lysine and pentosidine, in rat skin collagen. Journals of Gerontology. Series A: Biological Sciences and Medical Sciences, 50, B337-B341.
23. Chang, C.S., Kokontis, J., & Liao, S.T. (1988). Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science, 240, 324-326.
24. Chapman, I.M., Bach, M.A., Van Cauter, E., Farmer, M., Krupa, D., Taylor, A.M., . . . Thorner, M.O. (1996). Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects. Journal of Clinical Endocrinology & Metabolism, 81, 4249-4257.
25. Colao, A., Di Somma, C., Salerno, M., Spinelli, L., Orio, F., & Lombardi, G. (2002). The cardiovascular risk of GHdeficient adolescents. Journal of Clinical Endocrinology & Metabolism, 87, 3650-3655.
26. Conway, A.J., Handelsman, D.J., Lording, D.W., Stuckey, B., & Zajac, J.D. (2000). Use, misuse and abuse of androgens. The Endocrine Society of Australia consensus guidelines for androgen prescribing. Medical Journal of Australia, 172, 220-224.
27. Corona, G., Mannucci, E., Forti, G., & Maggi, M. (2009). Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? International Journal of Andrology, 32, 431-441.
28. Corrales, J.J., Burgo, R.M., Garca-Berrocal, B., Almeida, M., Alberca, I., Gonzalez-Buitrago, J.M., . . . Miralles, J.M. (2004). Partial androgen deficiency in aging type 2 diabetic men and its relationship to glycemic control. Metabolism, 53, 666-672.
29. Cuneo, R.C., Salomon, F., Watts, G.F., Hesp, R., & Sonksen, P.H. (1993). Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabolism, 42, 1519-1523.
30. Danesh, J., Collins, R., & Peto, R. (2000). Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation, 102, 1082-1085.
31. de Lorgeril, M., & Salen, P. (2005). Dietary prevention of coronary heart disease: The Lyon diet heart study and after. World Review of Nutrition and Dietetics, 95, 103-114.
32. de Lorgeril, M., & Salen, P. (2006). The Mediterranean diet in secondary prevention of coronary heart disease. Clinical and Investigative Medicine, 29, 154-158.
33. Diekman, C., Elmadfa, I., Koletzko, B., Puska, P., Uauy, R., & Zevenbergen, H. (2009). Summary statement of the International Expert Meeting: Health significance of fat quality of the diet. Barcelona, Spain, February 1-2, 2009. Annals of Nutrition & Metabolism, 54(Suppl. 1), 39-40.
34. Egerton, T., Brauer, S.G., & Cresswell, A.G. (2009). The immediate effect of physical activity on standing balance in healthy and balance-impaired older people. Australasian Journal on Ageing, 28, 93-96.
35. English, K.M., Jones, R.D., Jones, T.H., Morice, A.H., & Channer, K.S. (2002). Testosterone acts as a coronary vasodilator by a calcium antagonistic action. Journal of Endocrinological Investigation, 25, 455-458.
36. English, K.M., Mandour, O., Steeds, R.P., Diver, M.J., Jones, T.H., & Channer, K.S. (2000). Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. European Heart Journal, 21, 890-894.
37. English, K.M., Pugh, P.J., Parry, H., Scutt, N.E., Channer, K.S., & Jones, T.H. (2001). Effect of cigarette smoking on levels of bioavailable testosterone in healthy men. Clinical Science, 100, 661-665.
38. English, K.M., Steeds, R.P., Jones, T.H., Diver, M.J., & Channer, K.S. (2000). Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study. Circulation, 102, 1906-1911.
39. Epelbaum, J. (2008). Neuroendocrinology and aging. Journal of Neuroendocrinology, 20, 808-811.
40. Farzaneh-Far, R., Lin, J., Epel, E.S., Harris, W.S., Blackburn, E.H., & Whooley, M.A. (2010). Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. Journal of the American Medical Association, 303, 250-257.
41. Feldman, H.A., Longcope, C., Derby, C.A., Johannes, C.B., Araujo, A.B., & Coviello, A.D. (2002). Age trends in the level of serum testosterone and other hormones in middle-aged men: Longitudinal results from the Massachusetts male aging study. Journal of Clinical Endocrinology & Metabolism, 87, 589-598.
42. Florentin, M., Liberopoulos, E.N., Wierzbicki, A.S., & Mikhailidis, D.P. (2008). Multiple actions of high-density lipoprotein. Current Opinion in Cardiology, 23, 370-378.
43. Flurkey, K., Papaconstantinou, J., Miller, R.A., & Harrison, D.E. (2001). Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proceedings of the National Academy of Sciences of the United States of America, 98, 6736-6741.
44. Fofana, M., Maboundou, J.C., Bocquet, J., & Le Goff, D. (1996). Transfer of cholesterol between high density lipoproteins and cultured rat Sertoli cells. Biochemistry and Cell Biology, 74, 681-686.
45. Fontana, L., & Klein, S. (2007). Aging, adiposity, and calorie restriction. Journal of the American Medical Association, 297, 986-994.
46. Franco, O.H., Bonneux, L., de Laet, C., Peeters, A., Steyerberg, E.W., & Mackenbach, J.P. (2004). The polymeal: A more natural, safer, and probably tastier (than the polypill) strategy to reduce cardiovascular disease by more than 75%. British Medical Journal, 329, 1447-1450.
47. Friend, K., Iranmanesh, A., Login, I.S., & Veldhuis, J.D. (1997). Pyridostigmine treatment selectively amplifies the mass of GH secreted per burst without altering GH burst frequency, half-life, basal GH secretion or the orderliness of GH release. European Journal of Endocrinology, 137, 377-386.
48. Frye, E.B., Degenhardt, T.P., Thorpe, S.R., & Baynes, J.W. (1998). Role of the maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins. Journal of Biological Chemistry, 273, 18714-18719.
49. Gafni, A. (1997). Structural modifications of proteins during aging. Journal of the American Geriatrics Society, 45, 871-880.
50. Geer, E.B., & Shen, W. (2009). Gender differences in insulin resistance, body composition, and energy balance. Gender Medicine, 6(Suppl.1), 60-75.
51. Gilchrest, B.A., & Bohr, V.A. (1997). Aging processes, DNA damage, and repair. FASEB Journal, 11, 322-330.
52. Gray, A., Berlin, J.A., McKinlay, J.B., & Longcope, C. (1991). An examination of research design effects on the association of testosterone and male aging: Results of a meta-analysis. Journal of Clinical Epidemiology, 44, 671-684.
53. Gyllenborg, J., Rasmussen, S.L., Borch-Johnsen, K., Heitmann, B.L., Skakkebaek, N.E., & Juul, A. (2001). Cardiovascular risk factors in men: The role of gonadal steroids and sex hormone-binding globulin. Metabolism, 50, 882-888.
54. Harman, S.M., Metter, E.J., Tobin, J.D., Pearson, J., & Blackman, M.R. (2001). Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore longitudinal study of aging. Journal of Clinical Endocrinology & Metabolism, 86, 724-731.
55. Hartgens, F., & Kuipers, H. (2004). Effects of androgenic-anabolic steroids in athletes. Sports Medicine, 34, 513-554.
56. Hartgens, F., Rietgens, G., Keizer, H.A., Kuipers, H., & Wolffenbuttel, B.H. (2004). Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a). British Journal of Sports Medicine, 38, 253-259.
57. Herbst, K.L., Amory, J.K., Brunzell, J.D., Chansky, H.A., & Bremner, W.J. (2003). Testosterone administration to men increases hepatic lipase activity and decreases HDL and LDL size in 3 wk. American Journal of Physiology-Endocrinology and Metabolism, 284, E1112-E1118.
58. Holloszy, J.O. (2000). The biology of aging. Mayo Clinic Proceedings, 75(Suppl.), S3-S8.
59. Holloway, L., Butterfield, G., Hintz, R.L., Gesundheit, N., & Marcus, R. (1994). Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. Journal of Clinical Endocrinology & Metabolism, 79, 470-479.
60. Houston, D.K., Ding, J., Nicklas, B.J., Harris, T.B., Lee, J.S., Nevitt, M.C., . . . Health ABC Study. (2009). Overweight and obesity over the adult life course and incident mobility limitation in older adults: The Health, Aging and Body Composition Study. American Journal of Epidemiology, 169, 927-936.
61. Jaffe, M.D. (1977). Effect of testosterone cypionate on postexercise ST segment depression. British Heart Journal, 39, 1217-1222.
62. Jensen, T.K., Andersson, A.M., Hjollund, N.H., Scheike, T., Kolstad, H., & Giwercman, A. (1997). Inhibin B as a serum marker of spermatogenesis: Correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men. Journal of Clinical Endocrinology & Metabolism, 82, 4059-4063.
63. Jousilahti, P., Vartiainen, E., Tuomilehto, J., & Puska, P. (1999). Sex, age, cardiovascular risk factors, and coronary heart disease: A prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation, 99, 1165-1172.
64. Kantoff, P.W., Febbo, P.G., Giovannucci, E., Krithivas, K., Dahl, D.M., Chang, G., . . . Stampfer, M.J. (1997). A polymorphism of the 5 alpha-reductase gene and its association with prostate cancer: A case-control analysis. Cancer Epidemiology, Biomarkers & Prevention, 6, 189-192.
65. Kanungo, M.S. (1975). A model for ageing. Journal of Theoretical Biology, 53, 253-261.
66. Kapoor, D., Goodwin, E., Channer, K.S., & Jones, T.H. (2006). Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. European Journal of Endocrinology, 154, 899-906.
67. Kaushik, M., Sontineni, S.P., & Hunter, C. (2009). Cardiovascular disease and androgens: A review. International Journal of Cardiology. Advance online publication. doi:10.1016/j. ijcard.2009.10.033.
68. Kennedy, J.S., Polinsky, R.J., Johnson, B., Loosen, P., Enz, A., Laplanche, R., . . . Ebert, M.H. (1999). Preferential cerebrospinal fluid acetylcholinesterase inhibition by rivastigmine in humans. Journal of Clinical Psychopharmacology, 19, 513-521.
69. Khaw, K.T., & Barrett-Connor, E. (1991). Endogenous sex hormones, high density lipoprotein cholesterol, and other lipoprotein fractions in men. Arteriosclerosis and Thrombosis, 11, 489-494.
70. Krabbe, K.S., Pedersen, M., & Bruunsgaard, H. (2004). Inflammatory mediators in the elderly. Experimental Gerontology, 39, 687-699.
71. Kris-Etherton, P., Eckel, R.H., Howard, B.V., St. Jeor, S., & Bazzarre, T.L. (2001). AHA science advisory: Lyon diet heart study. Benefits of a mediterranean-style, national cholesterol education program/American Heart Association step I dietary pattern on cardiovascular disease. Circulation, 103, 1823-1825.
72. Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., . . . Nabeshima, Y.-C. (1997). Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature, 390, 45-51.
73. Lakatta, E.G., & Levy, D. (2003). Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises: Part II: The aging heart in health: Links to heart disease. Circulation, 107, 346-354.
74. Lamberts, S.W., van den Beld, A.W., & van der Lely, A.J. (1997). The endocrinology of aging. Science, 278, 419-424.
75. Lange, K.H., Andersen, J.L., Beyer, N., Isaksson, F., Larsson, B., Rasmussen, M.H.,. . . Kjaer, M. (2002). GH administration changes myosin heavy chain isoforms in skeletal muscle but does not augment muscle strength or hypertrophy, either alone or combined with resistance exercise training in healthy elderly men. Journal of Clinical Endocrinology & Metabolism, 87, 513-523.
76. Langer, C., Gansz, B., Goepfert, C., Engel, T., Uehara, Y., von Dehn, G., . . . von Eckardstein, A. (2002). Testosterone up-regulates scavenger receptor BI and stimulates cholesterol efflux from macrophages. Biochemical and Biophysical Research Communications, 296, 1051-1057.
77. Leow, M.K., & Loh, K.C. (2006). Controversial endocrine interventions for the aged. Singapore Medical Journal, 47, 569-579.
78. Li, Y., Sugiyama, E., Yokoyama, S., Jiang, L., Tanaka, N., & Aoyama, T. (2008). Molecular mechanism of age-specific hepatic lipid accumulation in PPARalpha (+/-):LDLR (+/-) mice, an obese mouse model. Lipids, 43, 301-312.
79. Lindeman, R.D., Tobin, J., & Shock, N.W. (1985). Longitudinal studies on the rate of decline in renal function with age. Journal of the American Geriatrics Society, 33, 278-285.
80. Lin-Su, K., & Wajnrajch, M.P. (2002). Growth hormone releasing hormone (GHRH) and the GHRH receptor. Reviews in Endocrine & Metabolic Disorders, 3, 313-323.
81. Liu, H., Bravata, D.M., Olkin, I., Nayak, S., Roberts, B., Garber, A.M., & Hoffman, A.R. (2007). Systematic review: The safety and efficacy of growth hormone in the healthy elderly. Annals of Internal Medicine, 146, 104-115.
82. Lombard, D.B., Chua, K.F., Mostoslavsky, R., Franco, S., Gostissa, M., & Alt, F.W. (2005). DNA repair, genome stability, and aging. Cell, 120, 497-512.
83. Looker, A.C., Orwoll, E.S., Johnston, C.C., Jr., Lindsay, R.L., Wahner, H.W., Dunn, W.L.,. . . Heyse, S.P. (1997). Prevalence of low femoral bone density in older U.S. adults from NHANES III. Journal of Bone and Mineral Research, 12, 1761-1768.
84. Lubahn, D.B., Joseph, D.R., Sullivan, P.M., Willard, H.F., French, F.S., & Wilson, E.M. (1988). Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science, 240, 327-330.
85. Maboundou, J.C., Fofana, M., Fresnel, J., Bocquet, J., & Le Goff, D. (1995). Effect of lipoproteins on cholesterol synthesis in rat Sertoli cells. Biochemistry and Cell Biology, 73(1-2), 67-72.
86. Manolakou, P., Angelopoulou, R., Bakoyiannis, C., & Bastounis, E. (2009). The effects of endogenous and exogenous androgens on cardiovascular disease risk factors and progression. Reproductive Biology and Endocrinology, 7, 44.
87. Marin, P., Holmang, S., Jonsson, L., Sjostrom, L., Kvist, H., Holm, G., . . . Björntorp, P. (1992). The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. International Journal of Obesity and Related Metabolic Disorders, 16, 991-997.
88. Marin, P., Krotkiewski, M., & Bjorntorp, P. (1992). Androgen treatment of middle-aged, obese men: Effects on metabolism, muscle and adipose tissues. European Journal of Medicine, 1, 329-336.
89. Marin, P., Lonn, L., Andersson, B., Oden, B., Olbe, L., Bengtsson, B.A., & Bjorntorp, P. (1996). Assimilation of triglycerides in subcutaneous and intraabdominal adipose tissues in vivo in men: Effects of testosterone. Journal of Clinical Endocrinology & Metabolism, 81, 1018-1022.
90. Marin, P., Oden, B., & Bjorntorp, P. (1995). Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: Effects of androgens. Journal of Clinical Endocrinology & Metabolism, 80, 239-243.
91. Medras, M., & Jozkow, P. (2009). Use of testosterone and anabolic androgenic steroids in sport. Endokrynologia Polska, 60, 204-209.
92. Morales, A. (2004). Andropause (or symptomatic late-onset hypogonadism): Facts, fiction and controversies. Aging Male, 7, 297-303.
93. Morales, A., & Lunenfeld, B. (2002). Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM (International Society for the Study of the Aging Male). Aging Male, 5, 74-86.
94. Morales, A., Schulman, C.C., Tostain, J., & Wu, F.C.W. (2006). Testosterone deficiency syndrome (TDS) needs to be named appropriately: The importance of accurate terminology. European Urology, 50, 407-409.
95. Morley, J.E., Kaiser, F.E., Perry, H.M., III, Patrick, P., Morley, P.M., Stauber, P.M., . . . Garry, P.J. (1997). Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism, 46, 410-413.
96. Morley, J.E., & Perry, H.M., III. (2003). Androgen treatment of male hypogonadism in older males. Journal of Steroid Biochemistry & Molecular Biology, 85(2-5), 367-373.
97. Munzer, T., Harman, S.M., Hees, P., Shapiro, E., Christmas, C., Bellantoni, M.F.,. . . Blackman, M.R. (2001). Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men. Journal of Clinical Endocrinology & Metabolism, 86, 3604-3610.
98. Munzer, T., Harman, S.M., Sorkin, J.D., & Blackman, M.R. (2009). Growth hormone and sex steroid effects on serum glucose, insulin, and lipid concentrations in healthy older women and men. Journal of Clinical Endocrinology & Metabolism, 94, 3833-3841.
99. Nakagawa, A., Nagaosa, K., Hirose, T., Tsuda, K., Hasegawa, K., Shiratsuchi, A., & Nakanishi, Y. (2004). Expression and function of class B scavenger receptor type I on both apical and basolateral sides of the plasma membrane of polarized testicular Sertoli cells of the rat. Development, Growth & Differentiation, 46, 283-298.
100. Neaves, W.B., Johnson, L., Porter, J.C., Parker, C.R., Jr, & Petty, C.S. (1984). Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men. Journal of Clinical Endocrinology & Metabolism, 59, 756-763.
101. Nieschlag, E., Swerdloff, R., Behre, H.M., Gooren, L.J., Kaufman, J.M., Legros, J.J., . . . Wu, F.C.W. (2006). Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Journal of Andrology, 27, 135-137.
102. Nikkila, M., & Heikkinen, J. (1990). High-density lipoprotein cholesterol and longevity. Age and Ageing, 19, 119-124.
103. Novak, L.P. (1972). Aging, total body potassium, fat-free mass, and cell mass in males and females between ages 18 and 85 years. Journal of Gerontology, 27, 438-443.
104. Obermayr, R.P., Mayerhofer, L., Knechtelsdorfer, M., Mersich, N., Huber, E.R., Geyer, G., & Tragl, K.H. (2005). The age-related down-regulation of the growth hormone/insulin-like growth factor-1 axis in the elderly male is reversed considerably by donepezil, a drug for Alzheimer's disease. Experimental Gerontology, 40, 157-163.
105. Page, S.T., Amory, J.K., Bowman, F.D., Anawalt, B.D., Matsumoto, A.M., Bremner, W.J., & Tenover, J.L. (2005). Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. Journal of Clinical Endocrinology & Metabolism, 90, 1502-1510.
106. Papadakis, M.A., Grady, D., Black, D., Tierney, M.J., Gooding, G.A., Schambelan, M., & Grunfeld, C. (1996). Growth hormone replacement in healthy older men improves body composition but not functional ability. Annals of Internal Medicine, 124, 708-716.
107. Partridge, L., & Gems, D. (2002). Mechanisms of ageing: Public or private? Nature Reviews. Genetics, 3, 165-175.
108. Petak, S.M., Nankin, H.R., Spark, R.F., Swerdloff, R.S., & Rodriguez-Rigau, L.J. (2002). American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients-2002 update. Endocrine Practice, 8, 440-456.
109. Pirke, K.M., & Doerr, P. (1975). Age related changes in free plasma testosterone, dihydrotestosterone and oestradiol. Acta Endocrinologica, 80, 171-178.
110. Popkin, B.M. (2010). Recent dynamics suggest selected countries catching up to US obesity. American Journal of Clinical Nutrition, 91, 284S-288S.
111. Purifoy, F.E., Koopmans, L.H., & Mayes, D.M. (1981). Age differences in serum androgen levels in normal adult males. Human Biology, 53, 499-511.
112. Racette, S.B., Weiss, E.P., Villareal, D.T., Arif, H., Steger-May, K., Schechtman, K.B.,. . . Washington University School of Medicine CALERIE Group. (2006). One year of caloric restriction in humans: Feasibility and effects on body composition and abdominal adipose tissue. Journals of Gerontology. Series A: Biological Sciences and Medical Sciences, 61, 943-950.
113. Rebuffe-Scrive, M., Lundholm, K., & Bjorntorp, P. (1985). Glucocorticoid hormone binding to human adipose tissue. European Journal of Clinical Investigation, 15, 267-271.
114. Riebe, D., Blissmer, B.J., Greaney, M.L., Garber, C.E., Lees, F.D., & Clark, P.G. (2009). The relationship between obesity, physical activity, and physical function in older adults. Journal of Aging and Health, 21, 1159-1178.
115. Rosano, G.M., Leonardo, F., Pagnotta, P., Pelliccia, F., Panina, G., Cerquetani, E.,. . . Chierchia, M.D. (1999). Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation, 99, 1666-1670.
116. Roubenoff, R. (2000). Sarcopenic obesity: Does muscle loss cause fat gain? Lessons from rheumatoid arthritis and osteoarthritis. Annals of the New York Academy of Sciences, 904, 553-557.
117. Rubens, R., Dhont, M., & Vermeulen, A. (1974). Further studies on Leydig cell function in old age. Journal of Clinical Endocrinology & Metabolism, 39, 40-45.
118. Sarkar, N.N. (2009). Hormonal profiles behind the heart of a man. Cardiology Journal, 16, 300-306.
119. Schaefer, E.J., Moussa, P.B., Wilson, P.W., McGee, D., Dallal, G., & Castelli, W.P. (1989). Plasma lipoproteins in healthy octogenarians: Lack of reduced high density lipoprotein cholesterol levels: Results from the Framingham Heart Study. Metabolism, 38, 293-296.
120. Schleich, F., & Legros, J.J. (2004). Effects of androgen substitution on lipid profile in the adult and aging hypogonadal male. European Journal of Endocrinology, 151, 415-424.
121. Schmidt, C.D., Dickman, M.L., Gardner, R.M., & Brough, F.K. (1973). Spirometric standards for healthy elderly men and women. 532 subjects, ages 55 through 94 years. American Review of Respiratory Disease, 108, 933-939.
122. Schupf, N., Costa, R., Luchsinger, J., Tang, M.X., Lee, J.H., & Mayeux, R. (2005). Relationship between plasma lipids and all-cause mortality in nondemented elderly. Journal of the American Geriatrics Society, 53, 219-226.
123. Seidell, J.C., Osterlee, A., Deurenberg, P., Hautvast, J.G., & Ruijs, J.H. (1988). Abdominal fat depots measured with computed tomography: Effects of degree of obesity, sex, and age. European Journal of Clinical Nutrition, 42, 805-815.
124. Sih, R., Morley, J.E., Kaiser, F.E., Perry, H.M., III, Patrick, P., & Ross, C. (1997). Testosterone replacement in older hypogonadal men: A 12-month randomized controlled trial. Journal of Clinical Endocrinology & Metabolism, 82, 1661-1667.
125. Snyder, P.J., Peachey, H., Hannoush, P., Berlin, J.A., Loh, L., Lenrow, D.A.,. . . Strom, B.L. (1999). Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. Journal of Clinical Endocrinology & Metabolism, 84, 2647-2653.
126. Sohal, R.S., & Weindruch, R. (1996). Oxidative stress, caloric restriction, and aging. Science, 273, 59-63.
127. Stanworth, R.D., & Jones, T.H. (2009). Testosterone in obesity, metabolic syndrome and type 2 diabetes. Frontiers of Hormone Research, 37, 74-90.
128. Stessman, J., Hammerman-Rozenberg, R., Cohen, A., Ein-Mor, E., & Jacobs, J.M. (2009). Physical activity, function, and longevity among the very old. Archives of Internal Medicine, 169, 1476-1483.
129. Szadkowska, I., Stanczyk, A., Aronow, W.S., Kowalski, J., Pawlicki, L., Ahmed, A., & Banach, M. (2010). Statin therapy in the elderly: A review. Archives of Gerontology and Geriatrics, 50, 114-118.
130. Taaffe, D.R., Pruitt, L., Reim, J., Hintz, R.L., Butterfield, G., Hoffman, A.R., & Marcus, R. (1994). Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men. Journal of Clinical Endocrinology & Metabolism, 79, 1361-1366.
131. Taylor, F., & Levine, L. (2009). Clomiphene citrate and testosterone gel replacement therapy for male hypogonadism: Efficacy and treatment cost. Journal of Sexual Medicine, 7(1, Pt. 1), 269-276.
132. Tenover, J.S., Matsumoto, A.M., Plymate, S.R., & Bremner, W.J. (1987). The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: Response to clomiphene citrate. Journal of Clinical Endocrinology & Metabolism, 65, 1118-1126.
133. Theodoraki, A., & Bouloux, P.M. (2009). Testosterone therapy in men. Menopause International, 15, 87-92.
134. Tilley, W.D., Marcelli, M., Wilson, J.D., & McPhaul, M.J. (1989). Characterization and expression of a cDNA encoding the human androgen receptor. Proceedings of the National Academy of Sciences of the United States of America, 86, 327-331.
135. Traish, A.M., Saad, F., & Guay, A. (2009). The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance. Journal of Andrology, 30, 23-32.
136. Trapman, J., Klaassen, P., Kuiper, G.G., van der Korput, J.A., Faber, P.W., van Rooij, H.C., . . . Brinkman, A.O. (1988). Cloning, structure and expression of a cDNA encoding the human androgen receptor. Biochemical and Biophysical Research Communications, 153, 241-248.
137. Valenti, G., Ceresini, G., & Maggio, M. (2007). Androgen deficiency in older men. Minerva Ginecologica, 59, 43-49.
138. Vermeulen, A., Rubens, R., & Verdonck, L. (1972). Testosterone secretion and metabolism in male senescence. Journal of Clinical Endocrinology & Metabolism, 34, 730-735.
139. Verzijl, N., DeGroot, J., Oldehinkel, E., Bank, R.A., Thorpe, S.R., Baynes, J.W., . . . Tekoppele, J.M. (2000). Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochemical Journal, 350(Pt.2), 381-387.
140. Villareal, D.T., Apovian, C.M., Kushner, R.F., & Klein, S. (2005). Obesity in older adults: Technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. American Journal of Clinical Nutrition, 82, 923-934.
141. Villareal, D.T., Fontana, L., Weiss, E.P., Racette, S.B., Steger-May, K., Schechtman, K.B.,. . . & Holloszy, J.O. (2006). Bone mineral density response to caloric restriction-induced weight loss or exercise-induced weight loss: A randomized controlled trial. Archives of Internal Medicine, 166, 2502-2510.
142. von Eckardstein, A., Kliesch, S., Nieschlag, E., Chirazi, A., Assmann, G., & Behre, H.M. (1997). Suppression of endogenous testosterone in young men increases serum levels of high density lipoprotein subclass lipoprotein A-I and lipoprotein(a). Journal of Clinical Endocrinology & Metabolism, 82, 3367-3372.
143. von Eckardstein, A., Nofer, J.R., & Assmann, G. (2001). High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arteriosclerosis, Thrombosis, and Vascular Biology, 21, 13-27.
144. Wald, N.J., & Law, M.R. (2003). A strategy to reduce cardiovascular disease by more than 80%. British Medical Journal, 326, 1419.
145. Walker, C., & Reamy, B. V. (2009). Diets for cardiovascular disease prevention: What is the evidence? American Family Physician, 79, 571-578.
146. Walter, M. (2009). Interrelationships among HDL metabolism, aging, and atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 29, 1244-1250.
147. Wang, C., Nieschlag, E., Swerdloff, R., Behre, H.M., Hellstrom, W.J., Gooren, L.J., . . . Wu, F.C. W. (2009). Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Journal of Andrology, 30, 1-9.
148. Webb, C.M., McNeill, J.G., Hayward, C.S., de Zeigler, D., & Collins, P. (1999). Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. Circulation, 100, 1690-1696.
149. Weidner, W., Behre, H., Beutel, M., Brahler, E., Hertle, L., Krause, W., . . . Popa, G. (2001). The ageing male. A consensus statement from the joint multidisciplinary working group of the German Society of Andrology, the German Society of Dermatology, the German Society of Endocrinology, and the German Society of Urology. Urologia Internationalis, 66, 160-161.
150. Weiss, E.P., Racette, S.B., Villareal, D.T., Fontana, L., Steger-May, K., Schechtman, K.B.,. . . Washington University School of Medicine, CALERIE Group. (2006). Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: A randomized controlled trial. American Journal of Clinical Nutrition, 84, 1033-1042.
151. Whitaker, R.C., Gooze, R.A., Hughes, C.C., & Finkelstein, D.M. (2009). A national survey of obesity prevention practices in Head Start. Archives of Pediatrics & Adolescent Medicine, 163, 1144-1150.
152. Williams, M.A., Haskell, W.L., Ades, P.A., Amsterdam, E.A., Bittner, V., Franklin, B.A.,. . . Stewart, K.J. (2007). Resistance exercise in individuals with and without cardiovascular disease: 2007 update: A scientific statement from the American Heart Association Council on Clinical Cardiology and Council on Nutrition, Physical Activity, and Metabolism. Circulation, 116, 572-584.
153. Wingard, D.L., Suarez, L., & Barrett-Connor, E. (1983). The sex differential in mortality from all causes and ischemic heart disease. American Journal of Epidemiology, 117, 165-172.
154. Wu, F.C., & von Eckardstein, A. (2003). Androgens and coronary artery disease. Endocrine Reviews, 24, 183-217.
155. Yin, L., Morita, A., & Tsuji, T. (2001). Skin aging induced by ultraviolet exposure and tobacco smoking: Evidence from epidemiological and molecular studies. Photodermatology, Photoimmunology & Photomedicine, 17, 178-183.
156. Yngve, A. (2009). A historical perspective of the understanding of the link between diet and coronary heart disease. American Journal of Lifestyle Medicine, 3(Suppl.1), 35S-38S.
157. Zmuda, J.M., Cauley, J.A., Kriska, A., Glynn, N.W., Gutai, J.P., & Kuller, L.H. (1997). Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former multiple risk factor intervention trial participants. American Journal of Epidemiology, 146, 609-617.